ALCON INC
ALC · XNYSCIK 1167379fmd_029FBM57GYNC2A139WDH9SJM4XManufacturing · Ophthalmic GoodsTemplate: Standard
Coverage: Jan 01, 2007 to Dec 31, 2025, 31 periods
| Line item | FY2010 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 7,179 | 6,792 | 7,153 | 7,508 | 6,833 | 8,291 | 8,717 | 9,455 | 9,911 | 10,401 |
| Cost of revenue | 1,675 | 3,588 | 3,961 | 3,719 | 3,830 | 3,577 | 3,910 | 4,141 | 4,328 | 4,592 |
| Gross profit | 5,504 | 3,204 | 3,192 | 3,662 | 2,940 | 4,652 | 4,748 | 5,247 | 5,512 | 5,745 |
| Realized investment gains (losses) | 36 | – | – | – | – | – | – | – | – | – |
| Research and development | 747 | 584 | 587 | 656 | 673 | 842 | 702 | 828 | 876 | 990 |
| Selling, general and administrative | – | 2,596 | 2,801 | 2,847 | 2,694 | 3,076 | 3,068 | 3,209 | 3,250 | 3,449 |
| Operating income | 2,475 | (77) | (248) | (187) | (482) | 580 | 672 | 1,039 | 1,413 | 1,360 |
| Interest expense | 9 | 27 | 24 | 113 | 124 | 120 | 134 | 189 | 192 | 204 |
| Interest and investment income | 29 | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | 35 | – | – | – | – | – | – | – | – | – |
| Income before taxes | 2,527 | (127) | (300) | (332) | (635) | 418 | 463 | 832 | 1,256 | 1,160 |
| Income tax expense | 317 | (383) | (73) | 324 | (104) | 42 | 128 | (142) | 238 | 180 |
| Net income from continuing operations | 2,210 | 256 | (227) | (656) | (531) | 376 | 335 | 974 | 1,018 | 980 |
| Net income | 2,210 | 256 | (227) | (656) | (531) | 376 | 335 | 974 | 1,018 | 980 |